Qualification of a chemotherapy-compounding robot
M Jobard, ML Brandely-Piat, F Chast… - Journal of Oncology …, 2020 - journals.sagepub.com
KIRO® Oncology (Kiro Grifols, Spain) is a robotic system for automated compounding of
sterile injectable drugs including intravenous cytotoxic treatments. The present article …
sterile injectable drugs including intravenous cytotoxic treatments. The present article …
[HTML][HTML] Burden of grade 3 or 4 liver injury associated with immune checkpoint inhibitors
…, J Chapron, B Deau-Fischer, ML Brandely-Piat… - JHEP Reports, 2023 - Elsevier
Background & Aims There is concern about the burden of liver injury in patients with cancer
exposed to immune checkpoints inhibitors (ICIs). Methods In a retrospective cohort study, we …
exposed to immune checkpoints inhibitors (ICIs). Methods In a retrospective cohort study, we …
Robotic chemotherapy compounding: A multicenter productivity approach
…, AM Marín, ML Brandely-Piat… - Journal of Oncology …, 2022 - journals.sagepub.com
Introduction The aim of this study is to compare productivity of the KIRO Oncology
compounding robot in three hospital pharmacy departments and identify the key factors to …
compounding robot in three hospital pharmacy departments and identify the key factors to …
[HTML][HTML] Stability of 25 mg/ml azacitidine suspensions kept in fridge after freezing
…, C Chanat, M Jobard, ML Brandely-Piat… - … Technology in Hospital …, 2017 - degruyter.com
Azacitidine is supplied as lyophilized powder to be reconstituted with sterile water for
injection. The molecule is very unstable in aqueous medium (temperature-dependent …
injection. The molecule is very unstable in aqueous medium (temperature-dependent …
COVID‐19 outbreak: An experience to reappraise the role of hospital at home in the anti‐cancer drug injection
…, V Cheneau, MC Pinel, ML Brandely‐Piat… - Cancer …, 2021 - Wiley Online Library
Background The COVID‐19 outbreak has posed considerable challenges to the health care
system worldwide, especially for cancer treatment. We described the activity and the care …
system worldwide, especially for cancer treatment. We described the activity and the care …
Cyclosporine eye drops: a 4-year retrospective study (2009-2013)
C Weber, BP ML, M Darrodes, K Jomaa… - Journal Francais D' …, 2015 - europepmc.org
Materials and methods Dispensations made from January 1st, 2009 through December 31st,
2013 were studied, including patient age, dose of cyclosporine and practice location of …
2013 were studied, including patient age, dose of cyclosporine and practice location of …
Robotic production of injectable anticancer drugs in hospital pharmacies
N Vo, R Desmaris, ML Brandely-Piat, M Vasseur… - Bulletin du …, 2023 - europepmc.org
Results The robotisation of the production of" chemotherapies" requires infrastructural
prerequisites, a reengineering of the manufacturing process and the patient journey. This …
prerequisites, a reengineering of the manufacturing process and the patient journey. This …
Production robotisée des préparations d'anticancéreux injectables en pharmacie hospitalière
N Vo, R Desmaris, ML Brandely-Piat, M Vasseur… - Bulletin du …, 2023 - Elsevier
Résumé Introduction À la suite du décret de 2005 portant sur la sécurisation du circuit du
médicament, la production des anticancéreux injectables (cytotoxiques, cytostatiques et …
médicament, la production des anticancéreux injectables (cytotoxiques, cytostatiques et …
PP-021 Evaluation of the surface contamination in a chemotherapy preparation unit before a process change
S Vengadessane, N Carre, M Jobard, ML Brandely-Piat… - 2017 - ejhp.bmj.com
Background Until April 2016, cytotoxic drugs were prepared in isolators placed in a
controlled atmosphere area (ISO 7) in the chemotherapy preparation unit (CPU). Since May …
controlled atmosphere area (ISO 7) in the chemotherapy preparation unit (CPU). Since May …
Subcontracting Workshop–GERPAC 2016
ML Brandely-Piat, L Bouchoud - Pharmaceutical Technology in …, 2017 - degruyter.com
Drug preparation requires an adequate number of qualified people and premises adapted.
Legal requirements for manufacturing drugs are constantly increasing. To face these …
Legal requirements for manufacturing drugs are constantly increasing. To face these …